Digestive Care (U.S. rights to market PERTZYE) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Digestive Care (U.S. rights to market PERTZYE) General Information

Description

The portfolio is a rights to market PERTZYE in United States. The PERTZYE is a unique pancreatic enzyme product, which helps in the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) in Pennsylvania, United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Bethlehem, PA
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Acquirer
Chiesi USA
Corporate Office
  • Bethlehem, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digestive Care (U.S. rights to market PERTZYE) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Digestive Care (U.S. rights to market PERTZYE)‘s full profile, request access.

Request a free trial

Digestive Care (U.S. rights to market PERTZYE) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Digestive Care (U.S. rights to market PERTZYE)‘s full profile, request access.

Request a free trial

Digestive Care (U.S. rights to market PERTZYE) FAQs

  • Where is Digestive Care (U.S. rights to market PERTZYE) headquartered?

    Digestive Care (U.S. rights to market PERTZYE) is headquartered in Bethlehem, PA.

  • What industry is Digestive Care (U.S. rights to market PERTZYE) in?

    Digestive Care (U.S. rights to market PERTZYE)’s primary industry is Buildings and Property.

  • Is Digestive Care (U.S. rights to market PERTZYE) a private or public company?

    Digestive Care (U.S. rights to market PERTZYE) is a Private company.

  • What is Digestive Care (U.S. rights to market PERTZYE)’s current revenue?

    The current revenue for Digestive Care (U.S. rights to market PERTZYE) is .

  • Who are Digestive Care (U.S. rights to market PERTZYE)’s investors?

    Digestive Care has invested in Digestive Care (U.S. rights to market PERTZYE).

  • When was Digestive Care (U.S. rights to market PERTZYE) acquired?

    Digestive Care (U.S. rights to market PERTZYE) was acquired on 29-Jul-2013.

  • Who acquired Digestive Care (U.S. rights to market PERTZYE)?

    Digestive Care (U.S. rights to market PERTZYE) was acquired by Chiesi USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process